RedHill Biopharma (RDHL) Net Cash Flow (2012 - 2022)
RedHill Biopharma (RDHL) posted quarterly Net Cash Flow of $4.8 million for Q4 2022, up 76.19% year-over-year from $2.7 million in Q4 2021, and up 140.68% quarter-over-quarter from -$11.7 million in Q3 2022.
RedHill Biopharma (RDHL) Net Cash Flow (2012 - 2022) Analysis & Trends
RedHill Biopharma (RDHL) has reported Net Cash Flow for 11 consecutive years, with $4.8 million the latest figure, recorded in Q4 2022.
- In Q4 2022, Net Cash Flow rose 76.19% year-over-year to $4.8 million; the TTM figure through Dec 2023 stood at $4.8 million (up 126.71% YoY), while the FY2025 annual figure was -$2.3 million, down 143.39% from the prior year.
- Net Cash Flow improved to $4.8 million in Q4 2022 per RDHL's latest filing, from -$11.7 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $48.5 million in Q1 2020 and bottomed at -$59.4 million in Q2 2020.
- Historically, Net Cash Flow has averaged -$1.0 million across 5 years, with a median of -$3.4 million in 2018.
- Annual changes were most pronounced in 2020 — Net Cash Flow jumped 727.8% — and 2021, when it tumbled 818.99%.
- RedHill Biopharma's Net Cash Flow stood at $10.2 million in 2018, then soared by 118.77% to $22.2 million in 2019, then plunged by 121.43% to -$4.8 million in 2020, then surged by 156.96% to $2.7 million in 2021, then surged by 76.19% to $4.8 million in 2022.
- Business Quant data shows RDHL's Net Cash Flow at $4.8 million in Q4 2022, -$11.7 million in Q3 2022, and -$1.8 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 4.78 Mn |
| Dec 31, 2022 | 4.78 Mn |
| Sep 30, 2022 | -11.75 Mn |
| Sep 30, 2022 | -11.75 Mn |
| Jun 30, 2022 | -1.83 Mn |
| Jun 30, 2022 | -1.83 Mn |
| Mar 31, 2022 | -9.10 Mn |
| Mar 31, 2022 | -9.10 Mn |
| Dec 31, 2021 | 2.71 Mn |
| Dec 31, 2021 | 2.71 Mn |
| Sep 30, 2021 | -20.02 Mn |
| Sep 30, 2021 | -20.02 Mn |
| Jun 30, 2021 | -24.17 Mn |
| Jun 30, 2021 | -24.17 Mn |
| Mar 31, 2021 | 46.39 Mn |
| Mar 31, 2021 | 46.39 Mn |
| Dec 31, 2020 | -4.76 Mn |
| Dec 31, 2020 | -4.76 Mn |
| Sep 30, 2020 | 2.79 Mn |
| Sep 30, 2020 | 2.79 Mn |